PHILADELPHIA, Sept. 24 /PRNewswire/ -- Today Astellas Pharma US, Inc. ("Astellas") announced the Launch of the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application (app) for smartphones. The app is designed to give physicians access to published criteria used to assess the nee
Source : http://www.prnewswire.com/news-releases/new-smartp...
Source : http://www.prnewswire.com/news-releases/new-smartp...



Technologies
Mobile Value Added Services (MVAS) Market by Solution, by End User, by Vertical, & by Geography - Global Forecast and Analysis to 2020 - Reportlinker Review




